Approval · Notice of Compliance 14971 · 2013
TYGACIL: Notice of Compliance 14971
Issued November 29, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14971
- Date
- November 29, 2013
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate drug product manufacturing site
- Therapeutic class
- Tetracycline antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TYGACIL | Not yet assigned | — |
Medicinal ingredients
- TIGECYCLINE 53 MG per VIAL